Clinical Trial Update: Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide [Phase 3]

View source ↗

Summary

Phase 3 AML trial comparing 8 Gy total body irradiation with fludarabine versus 12 Gy TBI with cyclophosphamide was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• 12 Gy total body irradiation with cyclophosphamide
• 8 Gy total body irradiation with fludarabine

Snippet

Sponsor: University Hospital Muenster | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: TERMINATED